Zinc oxide-aluminum oxide nanocomposite solid phase microextraction for diazepam and oxazepam trace determination.

J Chromatogr B Analyt Technol Biomed Life Sci

Department of Chemistry, Faculty of Science, University of Qom, Qom, Iran.

Published: January 2024

A new efficient ZnO-AlO nanocomposite (ZANC) was synthesized to form solid-phase microextraction (SPME) fiber. The prepared fiber was used for trace determination of benzodiazepines by gas chromatography-flame ionization detector in urine samples. The effective parameters on the extraction process including extraction time, salt percentage, desorption time and sample pH were optimized by a factorial design method. The method was evaluated at the optimum conditions and limits of detection (LODs) were calculated 20 µg/L for diazepam and oxazepam. The method repeatability for oxazepam and diazepam (50 µg/L, n = 4) was calculated at 8.8 % and 6.4 %. Also, the method reproducibility was obtained, 7.45 % and 6.61 % for oxazepam and diazepam (50 µg/L, n = 4). Also, fiber-to-fiber relative standard deviation (RSDs%) for the target analytes were less than 15.5 %. The method linearity is within the range of 62-500 µg/L for diazepam and oxazepam. The ZANC-SPME fiber showed a good lifetime (60 times) with high chemical stability. The high thermal stability of ZANC-SPME fiber was attained at 280 °C. The extraction results of poly dimethylsiloxan/divinyl benzene (PDMS/DVB) fiber were compared by ZANC-SPME fiber. Therefore, the method is proposed as a suitable technique for benzodiazepines detection in the urine sample.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2023.123966DOI Listing

Publication Analysis

Top Keywords

diazepam oxazepam
12
zanc-spme fiber
12
trace determination
8
oxazepam diazepam
8
diazepam 50 µg/l
8
50 µg/l n = 4
8
fiber
6
method
6
diazepam
5
oxazepam
5

Similar Publications

Pharmacokinetics of remimazolam, midazolam and diazepam in sheep.

Vet Anaesth Analg

December 2024

Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, USA; Kenneth L. Maddy Equine Analytical Chemistry Laboratory, School of Veterinary Medicine, University of California, Davis, CA, USA.

Objective: To model pharmacokinetics of three benzodiazepines and their metabolites in sheep.

Study Design: A nonblinded, prospective, experimental study.

Animals: A group of six adult Hampshire-Suffolk cross-bred sheep (three females, three castrated males), 73 ± 3 kg (mean ± standard deviation).

View Article and Find Full Text PDF

Background: There is a lack of knowledge on effective treatment methods for comorbid benzodiazepine dependence in populations undergoing opioid agonist treatment (OAT). Tapering and discontinuation of benzodiazepines has long been considered the standard treatment, even though there is limited evidence for this practice. There is also limited research on benzodiazepine agonist treatment; however, peer and clinical experiences indicate that such approaches may be beneficial for a subgroup of the patients with long-lasting benzodiazepine dependence not responding to other treatment approaches.

View Article and Find Full Text PDF

Background: A nationwide register-based cohort study from Finland including 48 124 incident benzodiazepines and related drug (BZDR) users aged 18-65 years who initiated use in 2006 and were not dispensed BZDRs during 2004-2005. The follow-up was 5 years or until death, whichever occurred first.

Aims: To investigate sociodemographic and clinical factors associated with high-dose use of BZDRs (i.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigated the link between anxiolytic drugs and the occurrence of Torsade de Pointes (TdP), a type of heart arrhythmia, using data from the FDA's Adverse Event Reporting System (FAERS) over a 30-year period.
  • Researchers identified 260 cases of TdP linked to anxiolytics and employed various data-mining algorithms to analyze the risk associated with these drugs.
  • The findings revealed six new signals of TdP risk linked to specific drugs, notably showing bromazepam and midazolam as the highest risk, while urging the need for more rigorous clinical studies to ensure patient safety.
View Article and Find Full Text PDF

Anesthesiologists often use benzodiazepines (BZDs) due to their remarkable amnestic and anxiolytic capabilities. Because of this, they are perfect for use during the perioperative phase, when patients' anxiety levels are already high. Remimazolam has replaced certain commonly used intravenous (IV) anesthetics due to its excellent safety profile, rapid onset of action, and short half-life.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!